AOL Web Search

  1. About 11,600 search results
  1. Web results:
  2. Press releases – BioCrea

    BioCrea Provides Update on Development Programs for Partners Radebeul, Germany, April 23, 2014 ... BioCrea’s unique PAMs act on a GABA A modulatory site that is different from benzodiazepine or steroid binding sites of currently marketed drugs. The subtype selectivity of these LT GABA A β2-preferring PAMs offers excellent efficacy in ...

  3. BioCrea Announces Upcoming Presentations At Leading ...

    BioCrea Announces Upcoming Presentations At Leading International Conferences - read this article along with other careers information, tips and advice on BioSpace

  4. Biocrea Company Profile | Owler

    BioCrea has 10 employees and an estimated annual revenue of $10M. Check out BioCrea's profile for competitors, acquisition history, news and more.

  5. Partnering – BioCrea

    BioCrea partnerships – accelerate therapeutic innovation. In partnering with BioCrea you will gain access to a portfolio of optimized drug candidates in a range of CNS diseases. With our knowledge and years of experience BioCrea is the prime partner for smart biotech and pharma companies worldwide.

  6. Biocrea - Home | Facebook

    Biocrea. 56 likes. jardines de Muro Verticales, pequeños espacios decorativos inspirados en los famosos jardines de Babilonia que llevan vida a cada...

  7. BioCrea Wins The Epilepsy Innovation Seal of Excellence Award

    Radebeul, Germany, January 9, 2014 - BioCrea GmbH (BioCrea), the first-in-class CNS drug discovery specialist validated through pharma partnerships, announced today that the Epilepsy Foundation (Maryland, US) has presented the Epilepsy Innovation Seal of Excellence Award to BioCrea in recognition of ...

  8. BioCrea GmbH: Private Company Information - Bloomberg

    BioCrea GmbH develops drugs to treat debilitating central nervous system diseases. The company primarily focuses on developing programs focusing on neurological and psychotic disorders. Its portfolio includes PDE10 inhibitor, a drug candidate in preclinical stage, to treat schizophrenia and ...

  9. BioCrea - BioPharmGuy

    BioPharmGuy data on file for BioCrea. Sponsored By: Est. 2008. Home; Purchase Data; Data Licensing; Drug Pipelines; Promote Your Listing; Find a CRO; Advertising; About; Contact; Founded 2010; Website Categories : Locations:, -----If you believe any of this information is incorrect, please let us know. privacy policy / terms and conditions ...

  10. BIO•CREAM 30 ml - Neocutis

    nightly care bio•cream 30 ml. the original psp® skincare cream formulated with an optimal blend of proteins, referred to as the “cadillac” of peptides!

  11. Biotie Therapies - Wikipedia

    In 2008, Biotie Therapies acquired the German pharmaceutical discovery and development company elbion GmbH in Radebeul. In 2010 Biotie Therapies all preclinical assets were transferred into a new company, biocrea GmbH, in which Biotie become a minority shareholder. In 2011, Biotie acquired a pharmaceutical company Synosia.

  1. Related searches biocrea

    biocrea gmbhbiotie therapies corp